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Abstract 
Eukaryotic cells contain a population of mitochondria, variable in number and shape, which 
in turn contain multiple copies of a tiny compact genome (mtDNA) whose expression and 
function is strictly coordinated with the nuclear one. mtDNA copy number varies between 
different cell or tissues types, both in response to overall metabolic and bioenergetics 
demands and as a consequence or cause of specific pathological conditions. Here we present 
a novel and reliable methodology to assess the effective mtDNA copy number per diploid 
genome by investigating off-target reads obtained by whole-exome sequencing (WES) 
experiments. We also investigate whether and how mtDNA copy number correlates with 
mitochondrial mass, respiratory activity and expression levels. Analyzing six different tissues 
from three age- and sex-matched human individuals, we found a highly significant linear 
correlation between mtDNA copy number estimated by qPCR and the frequency of mtDNA 
off target WES reads. Furthermore, mtDNA copy number showed highly significant 
correlation with mitochondrial gene expression levels as measured by RNA-Seq as well as 
with mitochondrial mass and respiratory activity. Our methodology makes thus feasible, at a 
large scale, the investigation of mtDNA copy number in diverse cell-types, tissues and 
pathological conditions or in response to specific treatments. 
 
  
Introduction 
Mitochondria play a range of critical roles in the life of eukaryotic cells (Pesole et al., 2012). 
They are the commonly referred to as the “power-stations” of the cell—for their provision of 
ATP through oxidative phosphorylation (OXPHOS), but they are also responsible for the 
biosynthesis of numerous macromolecules (lipids, proteins and nucleic acids) and contribute 
to the regulation of apoptosis, cell proliferation and motility. Individual cells, tissues and 
organs have distinct metabolic profiles and energy demands, which can change in response to 
environmental stimuli, alteration of physiological status or the onset of pathological 
conditions (Kunz, 2003, Leary et al., 1998, Leverve and Fontaine, 2001, Pfeiffer et al., 2001). 
Variation in mitochondrial respiratory capacity between tissues is also related to 
mitochondrial function, protein composition and morphology (Benard et al., 2006, Johnson et 
al., 2007a, Johnson et al., 2007b, Mootha et al., 2003, Pagliarini et al., 2008). 
Mitochondria are endowed of their own genetic system (mtDNA), a legacy of the 
endosymbiotic event that can be considered to represent the origin of eukaryotes and which 
occurred some 1.5–2 billion years ago (Lane and Martin, 2010). In mammals, the 
mitochondrial genome (mtDNA), a double stranded circular macromolecule, of around 16.5 
kbp in length, is uniparentally inherited from the mother. Numerous mitochondria, each with 
multiple copies of the mtDNA, are present in each cell and form a highly dynamic network, 
the result of continuous fusion and fission processes (Rafelski, 2013). The function and 
activity of mitochondria is strictly regulated through the coordinated expression of 
mitochondrial and nuclear genomes. The mtDNA copy number per diploid nuclear genome 
correlates with ATP production and can range between 1000 and 5000 (Bogenhagen and 
Clayton, 1974, Shmookler Reis and Goldstein, 1983). mtDNA copy number is specific to 
tissue types and developmental stages, is under strict regulation (Clay Montier et al., 2009, 
Moraes, 2001), apparently a reflection of differing energy requirements. Altered mtDNA 
copy number is associated with oxidative stress and with several pathological conditions, 
including neuromuscular diseases, cardiomyopathy, type 2 diabetes and cancer (Clay Montier 
et al., 2009). 
A comprehensive vision of tissue- and pathology-related variability in mtDNA copy number 
per cell is lacking and few studies have attempted to correlate mtDNA copy number with 
mitochondrial mass, respiratory activity or mitochondrial gene expression levels. 
We previously demonstrated that off-target reads from human whole-exome sequencing 
(WES) can be used to assemble mitochondrial genomes (Picardi and Pesole, 2012). Here, we 
investigate if the relative abundance of mtDNA reads obtained by WES experiments may be 
a reliable indicator of the effective mtDNA copy number per diploid genome, and whether 
and how mtDNA copy number correlates with global mitochondrial gene expression levels 
measured by RNA-Seq. 
In the current study, we have estimated mtDNA copy number by qPCR (Venegas et al., 
2011) as well as by the proposed WES-derived protocol for liver, kidney, brain, lung, muscle 
and heart samples from three age- and sex-matched human individuals. All samples were also 
subjected to whole transcriptome sequencing as well as to citrate synthase and cytochrome 
oxidase assays. 
A highly significant linear correlation between qPCR data and the frequency of mtDNA off 
target reads imply that, in addition to allowing the reconstruction of complete or nearly 
complete mitochondrial genomes (Picardi and Pesole, 2012), WES data permit accurate 
quantification of mtDNA copy number. Furthermore, mtDNA copy number showed highly 
significant correlation with mitochondrial gene expression levels as measured using RNA-
Seq as well as with key functional data. The relative abundance of distinct mtDNA-derived 
transcripts was tissue-specific and highly replicable. 
  
Materials and Methods 
 
Samples and nucleic acids extraction 
Six different post-mortem human snap-frozen tissues (brain, liver, lung, striated muscle, 
kidney and heart) from three unrelated healthy Caucasian individuals (males, aged 47–
54 years) were obtained from Cureline (South San Francisco, CA, USA). 
The three sample IDs are S7/11, S12/12 and S13/12, and all sample details are reported in 
Supplemental Table S1. 
DNA was purified using the DNeasy Blood and Tissue Kit (Qiagen, Hilden, Germany) 
according to the manufacturer's instructions, quantified and qualitatively checked on 
NanoDrop 2000c (Thermo Fisher Scientific, USA). 
Total RNA was purified using the RNeasy Plus Mini Kit (Qiagen, Hilden, Germany), 
according to the manufacturer's instructions. RNA quality was assessed on Agilent 
Bioanalyzer 2100, obtaining RIN (RNA Integrity Number) values ranging from 5 to 7, that 
were considered acceptable for RNA derived from post-mortem tissues. 
Quantification of mtDNA content 
Relative mtDNA copy number was measured by qPCR with SYBR detection using primers 
specific for the mitochondrial tRNA Leu(UUR) gene and the single copy nuclear ß-2-
microglobulin (ß2M) gene (Venegas et al., 2011). All reactions were performed using 5 ng of 
total DNA as template on a ABI Prism 7000 sequence detector system (Applied Biosystems, 
Foster City, CA, USA), according to this two-step thermal cycling protocol: 50 °C for 2 min 
(UDG pre-treatment); 95 °C for 10 min (initial denaturation); 40 cycles at 95 °C for 15 s and 
62 °C for 1 min, followed by a melting curve analysis (95 °C for 15 s, 60 °C for 30s and 
95 °C for 15 s) to verify the specificity and identity of the PCR product. Primers sequence, 
amplicon size and annealing temperature are reported in the Supplemental Table S2. 
The intensity of SYBR fluorescent signals were then analyzed by the SDS software (version 
1.2.3), and the CT value for each qPCR was used to calculate the mtDNA content by 
difference in CT values between the tRNA Leu(UUR) and ß2M genes (ΔCT). mtDNA content 
was obtained using the formula 2 × 2-(ΔCT). Results represent the average of three independent 
experiments performed on the same DNA preparation and are shown with standard 
deviations. 
 
Exome sequencing and mtDNA assembly 
Exome capture was performed using the TruSeq Exome Enrichment Kit (Illumina, San 
Diego, CA), according to the manufacturer's instructions. Briefly, for each tissue, a DNA 
library, including inserts ranging in size from 200 to 400 bp approximately, was prepared 
using the TruSeq DNA Sample Prep kit (Illumina). Then, each library was hybridated with 
biotinylated probes targeting the exonic regions (about 200,000 exons, covering about 62 Mb 
of the human genome). After two steps of enrichment with the probes, the captured exonic 
regions were sequenced on the Illumina HiSeq 2000 sequencer, at IGA Technology Services 
in Udine (Italy), generating for each tissue approximately 40 million of 100 bp paired-end 
reads. 
Exome reads were mapped onto the Revised Cambridge Reference Sequence (rCRS with 
GenBank accession number NC_012920) of human mtDNA (Andrews et al., 1999) using 
GSNAP program version 2013-07-14 (Wu and Nacu, 2010) since it enables the handling of 
circular genomes. 
Aligned reads were mapped again onto the complete human genome (assembly hg19 
including the rCRS sequence) using GSNAP in order to exclude read pairs also mapping on 
nuclear mitochondrial DNA sequences (i.e., Numts) (for further details see Picardi and 
Pesole, 2012). The complete mapping procedure was automated by using a custom python 
script (mapExome.py), available upon request. 
Mitochondrial reads in SAM format were converted into BAM and then pileup format using 
samtools (version 0.1.18) (Li et al., 2009). The final pileup file was parsed position-by-
position in order to calculate the distribution of nucleotides aligned at each position, 
removing bases with a quality score less than 25. For each position of the rCRS sequence, 
supported by at least 5 independent reads, the consensus base was calculated using a 
minimum confidence level of 0.75. 
Contiguous consensus positions were grouped in contigs and assembled into a final 
mitochondrial genome using a custom python script previously developed in our group 
(Picardi and Pesole, 2012). 
The relative amounts of off-target mtDNA reads were calculated as the number of reads 
mapping on mtDNA per million mapped reads. 
Strand-oriented RNA-Sequencing and analysis 
For each tissue, a strand-oriented RNA library was prepared to preserve information about 
which DNA strand was the original template during the synthesis of transcripts, thus offering 
strand orientation for detection of antisense transcription and providing information about 
regulatory relationships. 
The cytoplasmatic rRNA removal was performed for each total RNA sample using the Ribo-
Zero rRNA removal Kit (Epicentre, Madison, WI, USA). The rRNA-depleted RNA was used 
to prepare the stranded-oriented RNA-seq library using the TruSeq Stranded Total RNA 
Sample Prep Kit (Illumina, San Diego, CA, USA), according to the manufacturer's 
instructions. Briefly, each RNA was chemically fragmented prior to the random priming 
reverse transcription reaction for first strand cDNA generation. The fragmentation step 
resulted in an RNA-seq library including inserts ranging in size from approximately 100–
400 bp. During the second-strand synthesis, dUTP was incorporated in place of dTTP, thus 
preventing amplification of this strand during the subsequent PCR step and retaining strand 
information. cDNA libraries were sequenced on the Illumina HiSeq 2000 platform at IGA 
Technology Services in Udine (Italy), generating for each tissue sample approximately from 
27 to 35 million 100 bp paired-end reads. 
In order to investigate the expression level of mitochondrial-encoded transcripts, we used the 
reference annotation in Supplemental Table S3, which also includes long non-coding RNAs 
(Rackham et al., 2011). 
No reads that could be attributed uniquely to mature tRNAs were mapped, as expected, as the 
procedure used for the RNA extraction does not provide an enrichment for transcripts < 200 
nucleotides long (such as miRNAs and tRNAs). 
Sequences were first mapped against the human genome (hg19) using Tophat with default 
parameters, with a percentage of mapped reads in the different samples ranging from 88% to 
94%. Sequence read pairs that mapped on mtDNA as a correct forward-reverse pair, with a 
maximum insert size of 1000 bp were considered to be initial mitochondrial candidate reads. 
As expected, a non-negligible fraction of the latter (about 8% of the sequence pairs) resulted 
to be mapped on Numt regions of the nuclear genome as well, either as a singleton (only one 
of the two reads mapping), as a chimeric pair mapping on different nuclear chromosomes, or 
as a pair on the same chromosome. Since having a correct estimation of the number of 
sequence reads that could be reliably assigned to mitochondrial genes was essential for this 
study, we further investigated this issue. A comparison of matching against the mitochondrial 
and the nuclear genomes revealed that for more of the 90% of the ambiguously mapped 
sequence pairs a match was found for only one of the two paired reads on the nuclear 
genome. Only about 1% of the reads mapping as paired on the mitochondrial genome was 
mapped on Numts as correct forward–reverse pair, however with a number of mismatches 
equal to or greater than the one resulting from the mapping on the mitochondrion. 
All in all, these results show how mapping ambiguity between the Numt sequences and the 
mitochondrion can be resolved by employing paired-end sequences. All reads mapping as a 
correctly oriented pair on the mitochondrial sequence can be considered for further analyses 
independently of mapping on the nuclear genome. 
Starting from reads mapped on the mitochondrial genome, expression of genes was estimated 
by using the annotation summarized in Supplemental Table S3. Sequence reads were 
assigned to a gene when both sequence reads were completely contained within the gene 
boundaries and were assigned by directional sequencing to the same strand. Reads per 
kilobase per million (RPKM) values (Mortazavi et al., 2008) were then computed starting 
from these counts. 
RNA–DNA variations were detected using REDItools (Picardi and Pesole, 2013) 
Tissue homogenate preparation 
The PBI-Shredder, an auxiliary high-resolution respirometry (HRR) Tool, was used to 
prepare homogenate—in 0.2 M phosphate buffer (pH 8.0)—of frozen tissue specimens 
(Draxl et al., 2013), with high reproducibility of mitochondrial function as evaluated with 
HRR by means of Oxygraph-2 k OROBOROS®. Homogenate protein content was 
determined according to (Waddell, 1956) with bovine serum albumin used as a standard. 
Enzymatic activity measurements 
Citrate synthase (CS) and cytochrome c oxidase (COX) activities were measured by 
spectrophotometric standard methods. Each assay was performed at least in triplicate by 
using homogenate tissues subjected to three freeze–thaw cycles to disrupt membranes and 
expose mitochondrial enzymes. 
The reduction of 5,5-dithiobis(2-nitrobenzoic acid) (DTNB) by CS at 412 nm (extinction 
coefficient is 13.6 mM− 1 cm− 1) was followed in a coupled reaction with coenzyme A and 
oxaloacetate (Robinson and Srere, 1985). A reaction mixture of 0.1 mM acetyl-coenzyme A, 
0.2% Triton-x-100, 0.1 mM DTNB and 20–40 μg of homogenate protein was incubated at 
25 °C for 5 min. The reaction was initiated by the addition of 0.5 mM oxaloacetate. Results 
are expressed as nanomoles CoA formed per minute per mg homogenate protein. 
COX activity was measured by following the decrease of absorbance at 548–540 nm 
(extinction coefficient is 19.1 mM− 1 cm− 1), due to the oxidation of 40 μM ferrocytochrome c 
(reduced with substoichiometric concentrations of potassium ascorbate), for 90 s at 25 °C 
(see (Bobba et al., 2013)). Very stringent controls, including (i) test with cyanide, (ii) 
adequate homogenate proteins used for the reaction and (iii) gel-filtration of the reduced cyt c 
(in a superfine Sephadex G-25 column) to remove both excess of reductant and 
dimeric/multimeric form of cyt c, which per se can inhibit the reaction itself were performed 
to assure correct estimates of the Cox assay. Time-dependent absorbance changes were 
recorded with a Jasco double-beam/double-wavelength spectrophotometer UV-550. The rate 
of ferrocytochrome c oxidation, obtained as tangents to the initial part of the progress curves, 
is expressed as nanomoles cyt cox formed per minute per mg homogenate protein. 
Data were expressed as means ± standard deviation (S.D.) (n > 3) and analyzed with SPSS 
software by 1-way analysis of variance (ANOVA) for repeated measures followed by the 
post hoc Bonferroni test for multiple comparisons. Statistical differences were determined at 
P < 0.05. 
  
Results 
 
mtDNA copy number per diploid nuclear genome determined by qPCR 
We measured the relative mtDNA copy number in six tissue types (brain, lung, kidney, liver, 
heart and skeletal muscle) from three unrelated individuals (S7/11, S12/12 and S13/12) by 
qPCR. The highest mtDNA copy number was observed in heart tissue, followed by skeletal 
muscle, brain, liver, kidney and lung (Fig. 1 and Supplemental Table S4) consistent with the 
hypothesis that tissues with higher ATP requirement should show higher mitochondrial copy 
number. Differences in mtDNA content between the three subjects are particularly evident in 
brain and muscle. The low mtDNA copy number observed in the brain individual S13/12 
could be related to the cause of death (asphyxia), while the differences observed in muscle 
might reflect heterogeneous relative content of nuclei and mitochondria between muscle 
fibers or to different levels of habitual physical activity among the three sampled subjects. 
Correlation between mtDNA copy number and unspecific enrichment of mtDNA reads 
To evaluate whether the relative abundance of mtDNA reads among off-target exome 
enrichment reads was a reliable and effective estimator of mtDNA copy number, we 
generated and analyzed whole exome sequencing (WES) data for each of the 18 samples 
(Supplemental Table S5). The relative number of mtDNA reads among off-target WES reads 
was calculated using previously published methods (Picardi and Pesole, 2012). Bivariate 
linear correlation between mtDNA copy number and the relative amount of off-target 
mtDNA reads (Fig. 2) was highly significant (r2 = 0.92, P < 0.0001) confirming the 
effectiveness and reliability of the proposed approach for quantifying mtDNA copy number. 
Nucleotide variants in assembled mtDNA sequences 
For each tissue and individual, we assembled a complete mtDNA from whole exome reads 
(see Methods). Analysis of mtDNAs did not show significant somatic variations between 
different tissues of the same individual. Using stringent criteria (minimal coverage of 50 
reads and a base variation frequency higher than 10%), we found heteroplasmy higher than 
90% at position 310 of the D-Loop (T-to-C) in two of the three individuals. These 
observations were supported by the corresponding RNA-Seq data (Supplemental Table S6). 
The stringent filters employed were imposed to minimize false-discovery rate but might lead 
to the exclusion of poorly supported heteroplasmic sites. Relaxing the variation frequency, 
we also detected low frequency (5%) heteroplasmy at position 310 in the third individual as 
well as an additional low-frequency heteroplasmic position at D-Loop position 72 (T-to-C) in 
one individual (Supplemental Table S6). Both of these D-Loop variant positions are 
annotated as heteroplasmic sites in MITOMAP (Ruiz-Pesini et al., 2007). 
Sample matched comparisons between DNA (from whole exome) and RNA (from RNA-Seq) 
mitochondrial reads were used to identify potential post-transcriptional modification events. 
Only changes occurring at DNA homoplasmic sites with frequencies higher than 10% at the 
RNA level were considered. We observed tissue-specific nucleotide variations in four 
positions, three in heart and one in brain, consistently shared by all three individuals 
(Supplemental Table S7). Positions 1955 and 2617 (heart) were with the 16S rRNA, whereas 
site 905 (heart) fell in the 12S rRNA. Notably, at position 2617, we identified both A-to-U 
and A-to-G changes as previously reported (Bar-Yaacov et al., 2013). Position 8303 falls 
within the lysine tRNA and is found here for the first time as a target of a post-transcriptional 
modification event supported by RNA-Seq reads likely derived from polycistronic pre-
processed transcripts which might include tRNAs (Nardelli et al., 1994). In this site both A-
to-U and A-to-G changes were observed, but only in brain tissue. An additional RNA–DNA 
difference at position 295, described by Bar-Yaacov et al. (2013), was also observed in our 
samples, although not in all individuals and tissues because of the stringent filters employed 
(data not shown). 
Determination of mitochondrial mass and tissue energy requirement 
Citrate synthase (CS), a component of the tricarboxylic acid cycle, is a stably expressed 
mitochondrial matrix enzyme. Its specific activity is frequently used as an indicator of total 
mitochondrial mass (Figueiredo et al., 2008; Sarnat and Marin-Garcia, 2005, Kirby et al., 
2007). Cytochrome oxidase (COX) activity is often employed as a marker of OXPHOS 
activity since this enzyme (complex IV) constitutes the last step in the respiratory chain (RC), 
likely limiting its electron flux (Capaldi, 1990, Kunz et al., 2000, Larsen et al., 2012, Mazat 
et al., 2001, Villani and Attardi, 1997, Villani and Attardi, 2000, Villani et al., 1998). To 
evaluate variation in mitochondria content and respiratory capacity, CS and COX activities 
were determined spectrophotometrically in total homogenates from all 18 samples. 
Significant variation in CS and COX activities (normalized by the total homogenate protein 
content) were observed between tissues as well as between individuals (ANOVA). Tissue-
dependent differences again reflected known differences in energetic demands between 
tissues with heart, the organ that consumes most energy per mass unit (Goffart et al., 2004, 
Van den Bogert et al., 1993), showing the highest CS and COX specific activities with values 
4- to 12-fold and 1.2- to 2fold respectively higher than other tissues (Table 1). 
Knowing the amount of nuclear DNA (nDNA) and mtDNA per mg of protein lysate of the 
same tissue specimens, it was possible to normalize the CS and COX enzymatic activities per 
nDNA and mtDNA. Table 1 shows that CS activity/nDNA ratio varies greatly between 
tissues, again reflecting the tissue-specific differences in mitochondrial activities. As 
expected, the heart shows the highest ratio in all three individuals, in accordance with 
mtDNA relative abundance values and evidence that it has the highest mitochondrial content 
per cell (Fernandez-Vizarra et al., 2011). Moreover, the CS activity/mtDNA also differs 
markedly between samples, with higher values for heart, skeletal muscle and brain (Table 1). 
The highest COX activity/nDNA values were also associated with high energy-requirement 
tissues. However, COX activity/mtDNA values were, while variable, somewhat more 
consistent. 
Correlation between mtDNA copy number and mitochondrial mass and respiratory 
capacity 
We then evaluated if a correlation exists between the mtDNA copy number and the 
mitochondrial mass and the respiratory capacity in the different tissues. As shown in Fig. 3A 
and B, a positive and highly significant correlation was also found between either CS or COX 
activity per cell and the amount of mtDNA per cell. This indicates that the tissues which have 
the highest COX and CS activities have also the highest cellular mtDNA amount. 
Mitochondrial gene expression in different tissues evaluated by RNA-seq 
We carried out a strand-oriented RNA-Seq (2 × 100 bp paired-end, with random hexamer 
priming and no mitochondrial rRNA depletion) in the six tissue samples from the three 
individuals. Special attention was paid to minimize the impact of reads that could generate 
read mapping artifact to Numt (nuclear mitochondrial DNA) sequences (Calabrese et al., 
2012) and introduce biases into expression level estimates (see Methods). Analysis of cDNA 
reads that mapped to Numts revealed that while rRNA like reads were most predominant, 
around 90% of ambiguously mapped read pairs from protein coding ORFs derived from CO1 
or CO3 genes. 
Globally, from 4% to 27% of read-pairs (according to tissue) were of mitochondrial origin 
(see % mtDNA PE reads in Supplemental Table S8 and Methods). 
We observed a remarkably imbalanced level of expression between the mtDNA plus and 
minus strand, with about one thousand fold more reads mapping to the former. Furthermore, 
only about 0.36% of the reads mapping on the mtDNA plus strand resulted to be originated 
from the precursor RNA in contrast to over 85% of reads mapping on the minus strand 
(Supplemental Table S8 and Methods). Mapping of reads derived from the heavy strand 
covered the whole mitochondrion DNA sequence in all tissues (data not shown). The largest 
fraction of PE reads, around 95%, originated from 12S and 16S rRNA genes in all tissues 
considered. Other reads originated, as expected, mostly on annotated protein coding genes, 
with however sharp enrichment peaks also in the antisense strand of 16S rRNA, CO1 and 
ND5 genes (data not shown). Antisense transcripts of the ND5, ND6 and CytB genes have 
been demonstrated to correspond to three lncRNAs (Rackham et al., 2011), and we 
hypothesize that other antisense ncRNAs could originate in correspondence with the other 
peaks observed. 
Expression levels of the 11 mtDNA protein coding mature transcripts, ribosomal RNAs, and 
lncRNAs are reported in Supplemental Table S9, expressed as RPKM values as well as 
relative expression within the same tissue. The comparison of absolute RPKM values of the 
same gene across different samples shows high variability, reflecting the different 
concentrations of mitochondrial RNAs in each sample. The relative expression of genes 
within the same sample, instead, remains remarkably constant across the different tissues 
(Fig. 4). However, we observe a considerable variability of this measure, corresponding to a 
highly variable level of steady-state expression of the different mature transcripts, suggesting 
a remarkable and variable effect of post-transcriptional cleavage, processing and stability 
mechanisms in the regulation of gene expression, that are conserved across the different 
tissues investigated. 
Correlation of between mtDNA copy number and mitochondrial gene expression 
Finally, we sought to investigate potential correlation between mtDNA copy number and the 
expression level of mtDNA-encoded genes. The overall concentration of RNAs of 
mitochondrial origin in each tissue, expressed either as a percentage of non ribosomal 
mitochondrial reads on the overall number of mapped reads, or as the sum of RPKM values 
associated with non ribosomal genes, showed a remarkable correlation with the estimated 
mtDNA copy number, yielding a Pearson correlation of 0.81, as shown in Fig. 5 
(Supplemental Table S10). Similar correlation values (always around 0.8) were obtained by 
employing different measures for mitochondrial RNA concentration, namely, sum of genes 
RPKM values including rRNA genes, or fraction of mitochondrial RNA in the RNA-Seq 
sample, and also when computed against estimated mtDNA abundance derived from qPCR or 
exome sequencing (data not shown). 
  
Discussion 
 
The advent of high-throughput technologies for DNA and RNA sequencing has opened new 
avenues in biological research. A better understanding of the coordinated expression of the 
mitochondrial and nuclear genome will be critical for the characterization of novel processes 
underlying the functioning of eukaryotic cells. In particular, mtDNA copy number is a key 
functional parameter that varies greatly between different cell or tissues types, both in 
response to overall metabolic and bioenergetics demands and as a consequence or cause of 
specific physiological and pathological conditions. Alterations in mtDNA copy number have 
been related to aging (He et al., 2014), cancer (Zhang et al., 2013), neurodegenerative 
diseases (Podlesniy et al., 2013), diabetes (Chien et al., 2012) and other mitochondrial-related 
diseases (Liu et al., 2013). 
We previously reported a simple methodology for the reconstruction of complete or nearly 
complete mitochondrial genomes from off-target reads generated in whole exome sequencing 
experiments (WES) (Picardi and Pesole, 2012). 
Here, using WES data from six different tissues (brain, liver, lung, striated muscle, kidney 
and heart) from three unrelated healthy Caucasian individuals (males, aged 47–54) in 
conjunction with qPCR for experimental validation, we show that mtDNA copy number per 
cell can be reliably estimated from the relative amount of off-target reads of mitochondrial 
origin detected in WES data. As previously noted (Picardi and Pesole, 2012), it is worth 
underlining that the fraction of off-target mitochondrial reads is dependent on the exome 
enrichment protocol used, with the Illumina TruSeq Exome Enrichment Kit providing a 
higher amount of mitochondrial off-target reads than either Roche Nimblegen and Agilent 
SureSelect (Picardi and Pesole, 2012). We observed, as expected, strict tissue specificity of 
mtDNA copy number, reflecting the specific bioenergetics and metabolic demands of 
different tissues with heart and lung tissues showing the highest and lowest values, 
respectively. Inter-individual variations for the same tissues were also observed, and are 
likely related to the individual-specific physiological status and to the cause of death. 
Interestingly, we did not detect somatic variations in mtDNA sequences in different tissues 
from the same individual. Furthermore, the accuracy of sequence data was demonstrated by 
the overall consistency of gene and transcript sequences obtained by WES and RNA-Seq, 
respectively. A few putative post-transcriptional changes were detected, most of them in 
rRNA and tRNA genes, at sites already reported in the literature as susceptible to base-
specific post-transcriptional modification. 
We also show, by analyzing RNA-Seq data generated from the 18 samples, that a significant 
correlation exists, between the mtDNA copy number and the expression level of mt protein 
coding genes. Indeed, the paired-end strand-specific transcriptome sequencing allowed us to 
obtain reliable estimates of mature and precursor transcripts in sense and antisense 
orientations. We observed considerable variability in the expression levels of different 
protein coding transcripts, with CO1 and CO3 significantly more abundant than other genes 
(Fig. 4). On the other hand, the ND6 gene, the only L-strand gene encoding a polyA- 
transcript, is expressed at very low levels, totaling on average only 0.22% of all protein 
coding transcripts. Our data are not in accordance with the expression profile of 
mitochondrial mRNAs observed in Hela (Piechota et al., 2006) or 143B cells (Mercer et al., 
2011). However, it is quite expected that mitochondria from cultured human cells, 
particularly HeLa cells, do not reflect the transcriptional pattern observed in human tissues. 
The strand-specific sequencing performed also allowed the detection of stable antisense 
transcripts of ND5 and ND6 genes (Supplemental Table S9) as already identified in rat (Tullo 
et al., 1994) and human cell 143B cell line (Mercer et al., 2011). Interestingly, these antisense 
transcripts have different levels in the different tissues, with the highest levels in heart and 
kidney. 
Moreover, we found a remarkably significant positive correlation between mtDNA copy 
number and the mitochondrial mass, i.e., the CS/nDNA ratio, as well as the respiratory 
capacity, i.e., the COX/nDNA ratio, when all the tissues were considered together (Fig. 3), 
indicating that tissues with the highest mtDNA content i.e., heart, muscle and brain, have also 
the highest CS and COX activities per cell. Indeed, it is known that different metabolic 
profiles and variable energetic demands of different tissues are due to the inherently different 
functions or, in a single tissue, to changes in ATP demand due to physiological or 
pathological conditions (Kunz, 2003, Leary et al., 1998, Leverve and Fontaine, 2001, Pfeiffer 
et al., 2001). While our data suggest that mtDNA copy number is a critical parameter in the 
definition of quantitative aspects of respiratory function, mitochondria also exhibit tissue 
related variation in functional capacity, protein composition and morphology (Benard et al., 
2006, Fernandez-Vizarra et al., 2011, Johnson et al., 2007a, Johnson et al., 2007b, Mootha et 
al., 2003, Pagliarini et al., 2008). 
An aspect that must not be neglected—in the light of different metabolic profile of the three 
individuals—is that cellular adaptation to environmental and physiological constraints 
necessitates a fine tuning of the control of mitochondrial respiration, in response to changes 
in energy demand and substrate delivery. Accordingly, different tissues present large 
differences in the composition of the OXPHOS machinery and the organization of 
mitochondria (Chan, 2006, Fernandez-Vizarra et al., 2011), which, in addition to mtDNA 
copy number (Di Mauro and Bonilla, 2004), could influence their physiological activity. 
Nonetheless, mtDNA copy number remains a good proxy for mitochondrial activity for a 
sound conceptual reason: the mitochondrial mass or the activity of a respiratory enzyme are 
being related to the unit of genome that is needed to produce them (Fernandez-Vizarra et al., 
2008, Fernandez-Vizarra et al., 2011) as well as to its relevant nuclear counterparts (Mercer 
et al., 2011). 
In conclusion, the methodology presented here demonstrates the feasibility of large-scale 
detection of mtDNA copy number in diverse cell-types, tissues and pathological conditions. 
Given that several thousand exome sequence data sets are available in public repositories 
from different sources, the approach presented here is expected to generate a wealth of 
information that may contribute to a better understanding of nucleo-mitochondrion cross-talk 
and its involvement in health and disease. 
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Fig 1 
 
Relative mtDNA copy number in six tissues of three individuals (S7/11, S12/12 and S13/12) 
calculated by qPCR. Values represent the average of three independent experiments. 
 
 
 
 
  
Fig 2 
 
Linear correlation between the mtDNA copy number in the six tissues of three individuals 
(S7/11, S12/12 and S13/12) and off-target mtDNA reads of whole exome sequencing data, 
calculated performing a bivariate linear fit analysis (P < 0.0001). The amount of off-target 
mtDNA reads has been calculated as the number of mtDNA reads per million WES reads 
(see Supplemental Table S5). 
 
 
 
  
Fig 3 
 
Linear correlation between mtDNA copy number and mitochondrial mass and respiratory 
capacity. (A) Linear correlation between COX/nDNA and the mtDNA copy number in six 
tissues of three individuals (S7/11, S12/12 and S13/12) (P < 0.0001). (B) Linear correlation 
between CS/nDNA and mtDNA copy number in six tissues of three individuals (S7/11, 
S12/12 and S13/12) (P < 0.0001). 
Correlation was calculated using a bivariate linear fit analysis. 
 
 
 
 
  
Fig 4 
 
Relative levels of the mitochondrial mature mRNAs in the six examined tissues expressed as 
average for the three individuals (S7/11, S12/12 and S13/12). Values represent the ratio 
between the RPKM (reads per kilobase per million reads) of a specific mRNA and the total 
RPKM for all mature mRNAs (see Supplementary Table S9) calculated for each given tissue 
and individual. 
 
 
 
 
  
Fig 5 
 
Linear correlation between estimated mtDNA copy number and relative levels of mt mature 
transcripts expressed as average of RPKM values in the three individuals (S7/11, S12/12 and 
S13/12). Correlation was calculated using a bivariate linear fit analysis (P < 0.001). 
 
 
 
  
Table 1 
 
Citrate synthase (CS) and cytochrome oxidase (COX)-specific activity measurements and 
normalization by mtDNA and nDNA content. 
 
Data are the mean + standard deviation, with n = 4, obtained from six human tissues, liver, 
kidney, brain, lung, muscle and heart, from three age- and sex-matching individuals. 
 
 
Tissue 
CS-
specific 
activity 
COX-
specific 
activity 
CS/mtDNA CS/nDNA COX/mtDNA COX/nDNA 
liver_S7/11 530 ± 31 1357 ± 32 5196 27 13303 68 
liver_S12/12 245 ± 14 1813 ± 47 4803 20 35549 144 
liver_S13/12 297 ± 15 1411 ± 55 1650 7 7839 31 
kidney_S7/11 367 ± 18 1260 ± 53 3  336 13 11454 144 
kidney_S12/12 246 ± 11 1442 ± 44 6648 22 38972 126 
kidney_S13/12 426 ± 21 2832 ± 62 4260 11 28320 75 
brain_S7/11 164 ± 10 949 ± 37 10933 71 63266 413 
brain_S12/12 166 ± 11 1400 ± 43 6384 37 53846 318 
brain_S13/12 166 ± 9 1153 ± 30 12769 22 88693 154 
lung_S7/11 76 ± 5 1436 ± 41 4750 2 89750 36 
lung_S12/12 62 ± 5 1522 ± 42 5166 4 126833 98 
lung_S13/12 132 ± 7 1445 ± 47 2870 2 31413 21 
muscle_S7/11 196 ± 10 995 ± 28 8521 75 43260 383 
muscle_S12/12 475 ± 22 1363 ± 31 10106 131 29000 378 
muscle_S13/12 335 ± 12 1335 ± 33 14565 86 58043 342 
heart_S7/11 564 ± 28 1836 ± 41 16114 209 52457 680 
heart_S12/12 768 ± 37 2639 ± 55 10378 183 35662 628 
heart_S13/12 524 ± 25 1890 ± 47 12780 227 46097 821 
 
